iRemedy Archives | Be Korea-savvy
iRemedy Procures Supply of 500 Million More Low-Dead Space Syringes and Needles in Support of “Project Vaccinate”

iRemedy Procures Supply of 500 Million More Low-Dead Space Syringes and Needles in Support of “Project Vaccinate”

STUART, Fla., March 8 (Korea Bizwire) – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that the Company has arranged for the procurement of an additional 500 million low-dead space syringes and needles in association with iRemedy’s “Project Vaccinate” initiative, created to support global demand for FDA-approved [...]

iRemedy’s “Project Vaccinate” Program is Gaining Traction in 2021 with Over 130 Million Needles and Syringes Delivered

iRemedy’s “Project Vaccinate” Program is Gaining Traction in 2021 with Over 130 Million Needles and Syringes Delivered

STUART, Fla., Feb. 17 (Korea Bizwire) – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in association with the Company’s effort to procure and deliver one billion FDA-approved hypodermic needles and syringes in support of COVID-19 vaccination programs worldwide, over 130 million units have been delivered [...]

iRemedy™ Secures Factory Capacity for Needles and Syringes Required for Administration of One+ Billion COVID-19 Vaccinations

iRemedy™ Secures Factory Capacity for Needles and Syringes Required for Administration of One+ Billion COVID-19 Vaccinations

STUART, Fla., Nov. 18 (Korea Bizwire) – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration [...]